Henry Schein (NASDAQ:HSIC) Rating Increased to Buy at Wall Street Zen

Key Points

• Wall Street Zen upgraded Henry Schein to “Buy” from “Hold.” However, the broader analyst consensus remains “Hold,” with eight Buy, six Hold and one Sell rating and an average price target of $92.27.
• Henry Schein reported quarterly EPS of $1.27, beating estimates of $1.24, while revenue reached $3.46 billion and rose 6.7% year over year. The company issued fiscal 2026 EPS guidance of $5.29–$5.39.
• Shares opened at $89.77 and are near their 52-week high of $92.18; institutional investors own 96.62% of the stock, with several major investors recently increasing their positions.

Henry Schein (NASDAQ:HSIC - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued to investors on Monday.

Several other analysts have also commented on HSIC. Piper Sandler lifted their price target on shares of Henry Schein from $91.00 to $95.00 and gave the company an "overweight" rating in a research report on Wednesday, July 29th. Mizuho cut their target price on Henry Schein from $88.00 to $82.00 and set a "neutral" rating for the company in a research note on Wednesday, May 6th. Stifel Nicolaus set a $95.00 target price on Henry Schein in a research report on Wednesday, August 5th. Morgan Stanley reaffirmed an "underweight" rating and issued a $64.00 price target (up from $61.00) on shares of Henry Schein in a research note on Friday, April 24th. Finally, BTIG Research reiterated a "buy" rating and set a $100.00 price target on shares of Henry Schein in a report on Wednesday, August 5th. Eight equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $92.27.

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $89.77 on Monday. Henry Schein has a 1 year low of $61.94 and a 1 year high of $92.18. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.73 and a current ratio of 1.32. The company's fifty day moving average price is $84.81 and its 200 day moving average price is $79.07. The company has a market capitalization of $10.00 billion, a PE ratio of 26.17, a price-to-earnings-growth ratio of 1.71 and a beta of 0.80.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.03. The company had revenue of $3.46 billion for the quarter, compared to analysts' expectations of $3.37 billion. Henry Schein had a net margin of 2.96% and a return on equity of 15.97%. The firm's quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.10 EPS. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. On average, research analysts predict that Henry Schein will post 5.35 earnings per share for the current year.

Institutional Investors Weigh In On Henry Schein

Several large investors have recently bought and sold shares of HSIC. Ameriprise Financial Inc. grew its position in shares of Henry Schein by 3,275.2% during the second quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company's stock worth $165,594,000 after buying an additional 2,199,695 shares in the last quarter. Bank of Montreal Can lifted its stake in Henry Schein by 3,655.7% in the fourth quarter. Bank of Montreal Can now owns 2,144,773 shares of the company's stock worth $162,102,000 after acquiring an additional 2,087,666 shares during the last quarter. Norges Bank purchased a new position in Henry Schein in the fourth quarter worth approximately $88,116,000. Southpoint Capital Advisors LP grew its holdings in Henry Schein by 28.0% during the 1st quarter. Southpoint Capital Advisors LP now owns 3,200,000 shares of the company's stock worth $235,840,000 after acquiring an additional 700,000 shares in the last quarter. Finally, Bank of America Corp DE grew its holdings in Henry Schein by 204.2% during the 2nd quarter. Bank of America Corp DE now owns 995,375 shares of the company's stock worth $72,712,000 after acquiring an additional 668,182 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source